中新网上海10月15日电(记者陈静)记者今日获悉，中国肺癌防治联盟将启动对40岁以上，每年吸烟数量400支且肺部有结节肺癌高危人群肿瘤标志物筛查，专家将抽取其中1200个样本进行分析，最后得出的结果将推广用于肺癌的早期诊断。

Beijing on October 15, Shanghai(Reporter reiter)Reporters were told that,China lung cancer prevention alliance will start to 40 years old,Number of cigarettes every year 400 cigarettes and lung nodosity lung cancer screening high-risk groups tumor markers,Experts will extraction including 1200 samples to carry on the analysis,Finally the results of promotion will be used for the early diagnosis of lung cancer.

　　上海复旦大学附属中山医院呼吸科研究员宋元林说，过去30年，中国登记的肺癌死亡率增加了超过464%，肺癌已经超过肝癌，成为癌症死亡的首要病因。上海、辽宁更是肺癌高发城市。根据WHO的统计，2025年，中国新增肺癌人数将达每年100万。

Shanghai fudan university affiliated zhongshan hospital respiratory medicine researchers SongYuanLin said,Over the past 30 years,China registration of lung cancer mortality increased more than 464%,Lung cancer is more than liver cancer,Become the primary causes of cancer deaths.Shanghai/Liaoning is lung cancer high-risk city.According to the WHO statistics,In 2025,,Chinese New Year the number of lung cancer will reach 1 million.

　　今年4月成立的中国肺癌防治联盟将致力提高早期诊断作为关注焦点。宋元林说，起警示作用的肿瘤标志物如运用得当，将在诊断上事半功倍。他透露，11月将启动的筛查，会在两到三个月后得出结果，并预测，其中20%—30%会被诊断为肺癌。

In April this year established the China lung cancer prevention alliance will be devoted to improve early diagnosis as the focus.SongYuanLin said,The warning role of tumor markers such as using the proper,In diagnosis on the twice the result with half the effort.He revealed,November will start screening,Will be in two to three months after the result,And predict,20% - 30% will be diagnosed with lung cancer.

　　同日，旨在促进国际医疗诊断技术交流和发展的第五届“转科技委关爱”亚太区科学研讨会在此间举行，此次会议首次由中华医学会检验分会、国际临床化学和实验室医学联盟(IFCC)和雅培公司共同举办。IFCC主席GrahamBeastall博士表示，检验医学和诊断行业正处在一个激动人心的时代，新近成熟的检验技术为靶向测试和治疗提供了机会，也为提高实验室工作效率带来创新方法。

On the same day,Aims to promote the international medical diagnosis technology exchange and the development of the fifth"Turn KeJiWei love"Asia Pacific science conference held in here,For the first time the conference by the China medical association inspection branch/International clinical chemistry and laboratory medicine union(IFCC)And abbott laboratories jointly sponsor.GrahamBeastall IFCC chairman, says dr,Inspection of medical and diagnostic industry is in a exciting times,The newly mature inspection technology for targeted test and treatment provides opportunity,To improve the efficiency of laboratory work bring innovation method.

　　与会业内人士认为，中国“十二五”医改规划中强调提高医院就诊率及检验水平重要性，预期未来五年，中国市场对测试诊断需求会显著增加。

The personage inside course of study thinks,China"1025"In the planning of medical reform emphasis on improving hospital JiuZhenLv and test level importance,Expected the next five years,The Chinese market to test diagnosis demand will increase significantly.